Bush and Reed reported (Olin Chem 1987;33:821 -3) that the reaction of albumin with bromcresol purple but not with bromcresol green underestimated the concentration of albumin in syntheticallyobtained bilirubin-albumin (Bd) by 29%. Their unproven assumption was that chemically synthesized Bd behaved in a manner indistinguishable from the natural Bd in icteric serum. Here we verify that Bd, whether syntheticallyobtained or isolatedfrom serum, causes an underestimation of albumin in the bromcresol purple but not in the bromcresol green method. The molar ratio of Bd from either source to underestimated albumin approximates 1.0, suggesting that one molecule of Bd would react equivalently to a molecule of albumin in the bromcresol purple method. This underestimation might falsely suggest hypoalbuminemia in patients with increased serum Bd. Mo; Sigma grade, unconjugated bilirubin; Bu) in 1.0 mL of 0.1 mol/L NaOH and diluted to 100 mL with distilled water. We added 1.0 mL of the solution to 1.0 mL of 40 g/L human serum albumin ( 
hypoalbuminemia
Serum albumin, as a marker of liver function, is conveniently measured by several specific dye-binding methods. However, with the recognition that the concentration of a bilirubin-albumin covalent adduct (Bd) can become increased in the blood of adults with icteric sera (1), some decided to investigate whether Bd might affect any of these dye-binding methods for albumin. 3 Indeed, Bush and Reed (2) , using chemically synthesized Bd, showed that the artificial adduct caused a 29% underestimation of albumin by the bromcresol purple (BCP) but not the bromcresol green (BOG) method. An implicit but unsubstantiated assumption in that work was that the synthetic adduct behaved in the same way as authentic Bd in these albumin assays. Here, we directly compared the effects ofsynthetic Bd and of Bd isolated from serum on the same dye-binding
methods.
In addition to verifying the previous observation, our data further support the belief that above-normal concentrations of Bd can cause underestimation of serum albumin and might lead to false indications of hypoalbuminemia. 
Materials and Methods
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29 (4) (1 ± 2)C (Table 2 ). The ratio obtained with natural Bd was not different from that obtained with synthetic Bd or with the original serum analyzed before isolation. These ratios were close to 1.0 (but with large standard deviations) in the three bilirubin samples, suggesting that one molecule of increased Bd suppressed one molecule of dye-binding of BOP with serum albumin.
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To try to correct the albumin concentration that was affected by the increased Bd, we added moles of Bd to the moles of albumin obtained by the BOP method, because one molecule of Bd would lead to underestimation of one mole of albumin in the BOP method. The corrected values were compared with albumin concentrations determined immunologically (Table 1) method. However, in some cases with original icteric sera, the corrected value was >3 g/L greater (data not shown).
Discussion
The combination of conjugated hyperbilirubinemia and hypoalbuminemia is often associated with malfunction of the liver. In patients with severe hepatitis and other liver diseases, management of hypoalbuminemia is necessary. A prolonged increase of conjugated bilirubin in serum leads to formation of Bd, bilirubin that is bound covalently to serum albumin (12, 13) . It is convenient to determine the serum albumin concentration by the BOP method, which is specific for albumin and is widely used in clinical chemical laboratories. However, as reported by Bush and Reed (2), the method is affected by increased concentrations of synthetic bilirubin-albumm adduct. Because they used only chemically synthesized Bd adduct, their material was not necessarily the same as native Bd.
In this study, we confirmed their observation, using Bd isolated from serum. The natural Bd that was isolated from icteric adult serum had the following properties in common with synthetic Bd: suppressed dye-binding of BCP with albumin, and a Bd/suppressedalbumin molar ratio of nearly 1.0, suggesting that one molecule of Bd suppressed one molecule of dye-binding of BOP with serum albumin. Kuenzle et al. (5) reported that one molecule of synthetic Bd bound with one molecule of human serum albumin at high-affinity binding sites, where noncovalently unconjugated bilirubin (Bu) would bind. Wu (14) observed that Bd bound covalently to albumin at amino acid positions 124-217, high-affinity binding sites, and Bu bound at the same sites by electrostatic forces. However, both BOG and BOP bound reversibly to serum albumin, with the latter binding exclusively at high-affinity binding sites. We considered that these two dye-bindings were unaffected by the increase in Bu because the former did not bind to serum albumin at the same sites where Bu would bind and because the latter competed with Bu in binding affinity. Moreover, Bd, being bound tightly to serum albumin at high-affinity binding sites, would not be excluded by BOP. The binding affinity of Bc to serum albumin was considered to be lower than that of Bu (15) . Binding of Bu to secondary low-affinity binding sites was observed when the Bu/albumin molar ratio exceeded 1.0 (15, 16) . Although Kuenzle et al. (5) We speculate that some serum component present in hyperbilirubinemic serum might interact with dye-binding of BCP, because we observed the overestimation in the original serum but not in the isolated sample.
In conclusion, we could not determine the serum albumin concentration accurately by the BOP method in the presence of increased concentrations of Bd. Determination of serum albumin by the BOG method or by an immunological method is recommended for samples in which the Bd concentration is above normal.
